AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+14.47%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.73B
AUM Growth
+$355M
(+8.1%)
Cap. Flow
+$208M
Cap. Flow
% of AUM
4.4%
Top 10 Holdings %
Top 10 Hldgs %
47.54%
Holding
160
New
25
Increased
29
Reduced
25
Closed
13
Top Buys
| 1 |
Intel
INTC
|
$51.2M |
| 2 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$43.8M |
| 3 |
argenx
ARGX
|
$41.3M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$38.5M |
| 5 |
ACHL
Achilles Therapeutics plc American Depositary Shares
ACHL
|
$37.3M |
Top Sells
| 1 |
GDS Holdings
GDS
|
$73M |
| 2 |
Zillow
Z
|
$58.3M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$52.2M |
| 4 |
Alibaba
BABA
|
$46.5M |
| 5 |
uniQure
QURE
|
$25.3M |
Sector Composition
| 1 | Healthcare | 82.42% |
| 2 | Consumer Discretionary | 10.44% |
| 3 | Technology | 2.06% |
| 4 | Communication Services | 0.94% |
| 5 | Real Estate | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Zillow
Z
$20.2B
| $13M | 0.23% |
100,000
-450,000
| -82% | -$58.3M |
|
77
Iovance Biotherapeutics
IOVA
$800M
| $12.7M | 0.22% |
400,000
| – | – |
|
78
Solid Biosciences
SLDB
$448M
| $12.4M | 0.22% |
+150,000
| New | +$12.4M |
|
|
MRNS
79
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $12.4M | 0.22% |
800,000
+500,000
| +167% | +$7.74M |
|
80
Y-mAbs Therapeutics
YMAB
$390M
| $12.1M | 0.21% |
400,000
+114,972
| +40% | +$3.48M |
|
81
Design Therapeutics
DSGN
$339M
| $12M | 0.21% |
+400,000
| New | +$12M |
|
82
Instil Bio
TIL
$196M
| $11.3M | 0.2% |
+22,500
| New | +$11.3M |
|
83
Tencent Music
TME
$38.5B
| $11.3M | 0.2% |
+550,000
| New | +$11.3M |
|
84
Immunic
IMUX
$79.4M
| $11.2M | 0.2% |
700,000
| – | – |
|
|
EVLO
85
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $10.7M | 0.19% |
50,000
+15,000
| +43% | +$3.21M |
|
86
Ovid Therapeutics
OVID
$94.6M
| $10.1M | 0.18% |
2,500,000
| – | – |
|
87
Trip.com Group
TCOM
$46.6B
| $9.91M | 0.18% |
250,000
-250,000
| -50% | -$9.91M |
|
88
Kymera Therapeutics
KYMR
$3.1B
| $9.72M | 0.17% |
250,000
| – | – |
|
89
Stoke Therapeutics
STOK
$1.08B
| $9.71M | 0.17% |
250,000
| – | – |
|
|
DCPH
90
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $8.97M | 0.16% |
200,000
-300,000
| -60% | -$13.5M |
|
91
Olema Pharmaceuticals
OLMA
$432M
| $8.64M | 0.15% |
260,500
| – | – |
|
|
ARAV
92
DELISTED
Aravive, Inc. Common Stock
ARAV
| $8.64M | 0.15% |
1,311,291
| – | – |
|
93
Immunocore
IMCR
$1.78B
| $8.51M | 0.15% |
+200,000
| New | +$8.51M |
|
94
Spyre Therapeutics
SYRE
$1.02B
| $8.28M | 0.15% |
41,800
| – | – |
|
95
Dyne Therapeutics
DYN
$1.92B
| $8.15M | 0.14% |
525,000
+225,000
| +75% | +$3.49M |
|
|
96
GDS Holdings
GDS
$6.54B
| $8.11M | 0.14% |
100,000
-900,000
| -90% | -$73M |
|
|
HOOK
97
DELISTED
HOOKIPA Pharma
HOOK
| $8.07M | 0.14% |
59,962
-35,000
| -37% | -$4.71M |
|
|
SYRS
98
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $7.67M | 0.14% |
102,500
+27,500
| +37% | +$2.06M |
|
99
AC Immune
ACIU
$227M
| $7.61M | 0.13% |
1,000,000
| – | – |
|
100
Applied Therapeutics
APLT
$73.7M
| $7.5M | 0.13% |
400,000
+20,000
| +5% | +$375K |
|